A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. [electronic resource]
Producer: 20030403Description: 725-35 p. digitalISSN:- 0022-1899
- Adult
- Anti-HIV Agents -- administration & dosage
- Delivery, Obstetric
- Drug Therapy, Combination
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Infant
- Infant, Newborn
- Infectious Disease Transmission, Vertical -- prevention & control
- Labor, Obstetric
- Lamivudine -- administration & dosage
- Nevirapine -- administration & dosage
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Reverse Transcriptase Inhibitors -- administration & dosage
- Treatment Outcome
- Zidovudine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.